Tag: Insulin
Automated Insulin Delivery Ups Time in Target Glucose Range in T1D
Percentage of time in target glucose range increased with open-source AID versus sensor-augmented insulin pump
Preservation of C-Peptide Secretion Examined in Youth With T1D
Intensive glucose control for 24 months did not appear to prevent the decline in residual C-peptide secretion
Daily Insulin Dose Tied to Cancer Risk in Patients With T1DM
Daily insulin dose linked to cancer risk in multivariable model, with increasing cancer incidence in low-, medium-, high-dose insulin groups
California Will Produce Its Own Insulin to Bring Down Prices
As part of the state's new budget, $50 million will go directly to the development of low-cost insulin products
One in Seven Face Catastrophic Spending on Insulin
Older people with low family incomes face greatest risk for high out-of-pocket spending relative to income
ENDO: Fracture Risk Up With Insulin Compared With Metformin in T2DM
Risk for major osteoporotic fractures up for insulin versus metformin for those with HbA1c <7 percent, BMI <25 kg/m2
ADA: Insulin Delivery Systems Compared in Type 1 Diabetes
Open-source automated insulin delivery compared to sensor augmented pump therapy in adults and children with T1D
Effects of Intranasal Insulin on Cognition, Mobility Studied in Elderly
Evidence from phase 2 trial suggests positive effects on cognition and gait in elderly patients with type 2 diabetes
House Passes Bill To Limit Insulin Costs to $35 a Month
Bill now has to pass the Senate with at least 10 Republican votes
Adding Tirzepatide to Insulin Glargine Ups Glycemic Control in T2DM
For adults with type 2 diabetes and inadequate glycemic control, glycemic control improved with addition of tirzepatide versus placebo